Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Withania somnifera KSM-66
Extrait premium de racine d'ashwagandha à spectre complet avec la plus haute concentration de withanolides, étudié cliniquement.
Ashwagandha KSM-66 is a standardized full-spectrum root extract of Withania somnifera, clinically studied for reducing cortisol, supporting testosterone levels, modulating thyroid function, and enhancing cognitive performance. Its primary active compounds include withanolides (notably withaferin A), alkaloids, and saponins, which collectively exert adaptogenic, anti-inflammatory, and neuroprotective effects.
Ashwagandha KSM-66 acts as an adaptogen primarily by modulating the hypothalamic-pituitary-adrenal (HPA) axis, reducing serum cortisol levels and increasing DHEA-S. It enhances GABAergic activity via binding to GABAA receptors, contributing to anxiolytic and sedative effects. Withaferin A inhibits NF-κB signaling, reducing pro-inflammatory cytokines. The extract also supports thyroid function by increasing T4 to T3 conversion via stimulation of thyroid peroxidase activity. Additionally, it may improve testosterone levels by reducing cortisol-induced suppression of luteinizing hormone and by enhancing Leydig cell function.
Extrait premium de racine d'ashwagandha à spectre complet avec la plus haute concentration de withanolides, étudié cliniquement.
Ashwagandha KSM-66 is a standardized full-spectrum root extract of Withania somnifera, clinically studied for reducing cortisol, supporting testosterone levels, modulating thyroid function, and enhancing cognitive performance. Its primary active compounds include withanolides (notably withaferin A), alkaloids, and saponins, which collectively exert adaptogenic, anti-inflammatory, and neuroprotective effects.
Ashwagandha KSM-66 acts as an adaptogen primarily by modulating the hypothalamic-pituitary-adrenal (HPA) axis, reducing serum cortisol levels and increasing DHEA-S. It enhances GABAergic activity via binding to GABAA receptors, contributing to anxiolytic and sedative effects. Withaferin A inhibits NF-κB signaling, reducing pro-inflammatory cytokines. The extract also supports thyroid function by increasing T4 to T3 conversion via stimulation of thyroid peroxidase activity. Additionally, it may improve testosterone levels by reducing cortisol-induced suppression of luteinizing hormone and by enhancing Leydig cell function.